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Abstract   27 
Thyroid hormones regulate adipogenic differentiation, lipogenic and lipolytic metabolism and 28 
mitochondrial activity in adipose tissue. T3 levels in tissues are regulated by the deiodinase 29 
enzymes.  30 
Objective: To study the activity and mRNA expression of the 5’ outer-ring deiodinases (D1 31 
and D2) and thyroid hormone concentrations in rat white adipose tissue (WAT), where only 32 
D1 activity had been described.  33 
Methods: Control, thyroidectomized and thyroid hormone treated rats were used. D1 and D2 34 
mRNA were determined in WAT by qRT-PCR using Taqman probes, D1 and D2 activities 35 
were determined using rT3 and T4 as substrates. T4 and T3 were measured by 36 
radioimmunoassay in plasma, liver and adipose tissue. 37 
Results: D1 and D2 mRNAs are present in epididymal rat WAT with similar abundance, 38 
which are 7% of the D2 mRNA levels in BAT and 1% that of D1 in liver. The Kms in WAT 39 
are 40 nM T4 for D2 and 0.35 µM rT3 for D1. Both D1 and D2 are regulated in rat 40 
epididymal WAT by thyroidal status. T4 and T3 concentrations in plasma, liver and WAT 41 
decreased after thyroidectomy (Tx) and recovered after treatment with T4+T3. Both D1 and 42 
D2 mRNA increased in WAT from Tx rats and T4+T3 treatment inhibited them, especially 43 
D2 mRNA. D1 activity did not changed with thyroidal status, while D2 activity was inhibited 44 
by T4+T3.  45 
Conclusions: the presence of both deiodinases in WAT suggests important roles in regulating 46 
T3 bioavailability for adipose tissue function and regulation of lipid metabolism and 47 
thermogenesis. 48 
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List of abbreviations: 52 
BAT: brown adipose tissue; D1: type1 deiodinase; D2: type 2 deiodinase; D3: type3 53 
deiodinase; DTT: dithiothreitol; HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; 54 
Km: Michaelis-Menten constant; PCR: polymerase chain reaction; PTU: 6-propyl-2-55 
thiouracil; qRT-PCR: quantitative Real-time PCR; rT3: reverse triiodothyronine; T3: 56 
triiodothyronine; T4: thyroxine; Tx: thyroidectomized; UCP1: uncoupling protein 1; Vmax: 57 
maximal velocity; WAT: white adipose tissue. 58 
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Introduction   64 
Deiodinases are selenoenzymes that regulate thyroid hormone concentrations in tissues. 65 
Two isoenzymes, D1 and D2, catalyze 5’deiodination producing T3 from T4. D1 is present in 66 
liver, kidney and thyroid. D1 Km is 0.2-0.5 µM [1], is inhibited by PTU, increases in 67 
hyperthyroidism and decreases in hypothyroidism, except thyroid D1 which increases in 68 
hypothyroidism, by thyrotropin stimulation [2]. D2 is present in pituitary, brain, BAT and 69 
other tissues, is not inhibited by PTU, its Km in nanomolar range. D2 increases in 70 
hypothyroidism and produces T3 for local needs. D3, the main T3 degradation pathway, 71 
catalyzes inner ring deiodination of T4 and T3, leading to inactive metabolites. 72 
D2 is essential for the regulation of T3 availability during specific events of development, 73 
in the ear, retina, brain or BAT. T3 is required for the differentiation program of adipocytes 74 
[3], regulating the expression of genes involved in the differentiation and metabolism of 75 
adipose tissue. Most studies demonstrating the importance of deiodinases, specifically D2, 76 
have been performed in BAT, where T3, locally produced by D2, is important for full 77 
thermogenesis, UCP1 expression and lipogenesis [4-7]. So far, no studies have been 78 
performed on D1 or D2 abundance in WAT, its hormonal regulation or potential role in 79 
different metabolic processes, though D1 activity in WAT was found when D2 was reported 80 
in BAT [8]. Some studies have shown induction of brown adipocytes in inguinal WAT 81 
depots, using UCP1 and D2 as markers [9, 10]. In this respect epididymal WAT is considered 82 
“pure” WAT, never converted into BAT even under extreme cold exposure, as opposed to 83 
inguinal WAT considered “convertible” adipose tissue [11]. In humans, WAT represents 15-84 
20% of the body weight in lean subjects and this percentage is much higher in obese people 85 
(50%). Thus, WAT might represent one of the largest pools of thyroid hormones.  In addition, 86 
if WAT can be converted into BAT (inducing UCP1), WAT represents a potential therapeutic 87 
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target to increase energy expenditure in obesity. Here we studied the presence and regulation 88 
by thyroid status of D1 and D2 activities and mRNA levels in rat WAT. 89 
 90 
Materials and Methods  91 
Animals and treatments 92 
Protocols following the European Community guidelines were approved by our ethic 93 
Committee. Male Wistar rats were divided in 3 groups: Control, Tx and Tx rats treated with 94 
T4+T3 (2.4 µg T4+0.4 µg T3/day/100 g body weight) as described [12]. Plasma and organs 95 
were dissected out and frozen on dry ice. Epididymal WAT was carefully dissected avoiding 96 
the reproductive male organs.  97 
Analytical procedures 98 
Determination of D1 and D2 activities. D1 and D2 activities were assayed in WAT 99 
homogenates (1:8, weight/volume) using 0.32 M sucrose, 10 mM Hepes and 10 mM DTT. 100 
Homogenates were centrifuged 5 minutes at 1000 rpm to separate the upper lipid cake, the 101 
infranatant was used to measure deiodinase activities.  102 
D1 activity: 60.000 cpm [
125
I]-rT3/sample, 100 nM rT3 and 5 mM DTT, for 1 h at 37 C 103 
using 20-30 µg protein/ 100 µl [13]. D2 activity: 100.000 cpm [
125
I]-T4/tube, 2 nM T4+ 1 104 
µM T3, 20 mM DTT and 1 mM PTU/100 µl, using the same conditions and protein [14]. For 105 
kinetic analysis: 2-500 nM rT3 and 5 mM DTT were used for D1 and 1-50 nM T4 and 20 106 
mM DTT for D2. 107 
D1 and D2 mRNA 108 
Total RNA was extracted using the RNeasy lipid tissue (Quiagen). D1 and D2 mRNAs 109 
were measured by qRT-PCR, using Taqman probes (Rn00572183m1, Rn00581867m1, 110 
Applied Biosystems). After normalization to 18S rRNA, the fold-change in mRNA 111 
expression was calculated by the 2
-Ct
 method. 112 
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Determination of thyroid hormone concentrations.  113 
Thyroid hormone concentrations were determined by RIA in plasma, liver and WAT, after 114 
extraction and purificatio [15]. High specific activity T4, rT3 and T3 labelled with [
125
I] were 115 
synthesized as described [15]. 116 
Statistical analysis 117 
Mean values (±SEM) are given. Significant differences were achieved by one-way 118 
ANOVA analysis.119 
 120 
Results  121 
Presence and characterization of D1 and D2 in epididymal rat WAT 122 
We first identified D1 in WAT, using PCR amplification and gel separation (not shown). 123 
Then, we did tritation curves using qRT-PCR using Taqman probes (Figure 1A), confirming 124 
that D1 and D2 mRNA were present in rat epididymal WAT being D2 mRNA abundance 125 
higher than D1 mRNA (approx. double). WAT D1 mRNA abundance was less than 1% of 126 
liver D1 and WAT D2 mRNA abundance was about 7% of BAT D2 (Figure 1B, 1C).  127 
We then analyzed D1 and D2 activities in WAT. First, the kinetic characteristics were 128 
determined; for D2: Km=40 nM T4 and Vmax= 3 pmol/h/mg protein and for D1: Km= 0.35 129 
µM rT3 and Vmax= 6-18 pmol/h/mg protein (C and Tx rats, respectively). D1 activity was 130 
higher in perirenal WAT; D2 activitiy was similar in perirenal and epididymal WAT and 131 
lower in subcutaneous WAT (results not shown). 132 
Regulation of D1 and D2 in rat WAT by thyroid status 133 
Deiodinases are regulated by thyroid status in most tissues. To study this regulation we 134 
used control, Tx and T4+T3-treated rats. The thyroidal status was checked measuring T4 and 135 
T3 concentrations in plasma, liver and WAT. Figure 2 shows that T4 and T3 decreased after 136 
thyroidectomy in all samples. Treatment of Tx rats with T4+T3 reverted T4 to control values 137 
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in plasma and liver, while WAT T4 doubled the values in control rats, pointing to a 138 
preferential T4 uptake in WAT. The treatment also increased T3 in all cases, reaching control 139 
values in WAT and plasma, while liver T3 concentrations did not fully recovered. 140 
D1 and D2 mRNA increased in WAT from Tx rats (Figure 1D, 1E), and T4+T3 treatment 141 
inhibited them to control values for D1, and to less than 50% of control values for D2 mRNA. 142 
Opposite to the mRNA responses no variation was observed in D1 and D2 activities, except 143 
for D2 activity that was inhibited in the T4+T3 group. 144 
 145 
Discussion  146 
D1 activity was identified in WAT in 1983 together with D2 activity in BAT [8], 147 
establishing clear differences between BAT and WAT. Then, a full UCP1 expression was 148 
associated to T3 produced by D2 in BAT [4] and this was recently confirmed in the D2 149 
knockout mice [7].  150 
Herein, we describe that D2 is also present in WAT, both at mRNA and activity levels. We 151 
used epididymal WAT, the purest of all WAT locations, never converted into BAT under cold 152 
exposure; in contrast, inguinal fat, is considered “convertible” adipose tissue, that is 153 
transformed into BAT under several stimuli [11, 16]. Other WAT locations (perirenal, 154 
periuterine) are considered a mix of BAT and WAT in terms of UCP1 induction [17]. UCP1 155 
levels in epidydimal WAT are near detection limits by qRT-PCR and less than 5% those in 156 
inguinal WAT (unpublished). Therefore it is unlikely that D2 could come from residual BAT 157 
cells present in epidydimal WAT. 158 
Despite the 1983 report, WAT D1 had not been further studied, possibly because lipids 159 
cause technical difficulties, which we solved by improving the RNA isolation using a specific 160 
kit to avoid lipids and specific Taqman probes. Regarding D1 and D2 activities, we 161 
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characterized them in terms of their kinetic characteristics which were in the same ranges as 162 
in other tissues [1].  163 
Thyroid status, a main regulator of deiodinases, was studied in this work. Both deiodinases 164 
mRNAs were up-regulated in hypothyroidism. WAT D2 increased as expected in 165 
hypothyroidism. WAT D1 also  increased, responding to hypothyroidism as thyroid D1 [2]. 166 
Regarding deiodinase activities, WAT D2 followed a pattern similar to D2 mRNA, as it 167 
tended to increase in hypothyroidism and decreased in T4+T3-treated rats, reflecting the high 168 
WAT T4 concentrations. We showed recently increased D2 mRNA in parallel to D2 activity 169 
levels in human subcutaneous fat [18]. D1 activity did not changed among groups in our 170 
study. Other studies have shown discrepancies between D1 and/or D2 mRNA and activity 171 
levels [19], probably due to posttranscriptional modifications. 172 
Recently, D1 activity in WAT was related to adiposity, increasing by high-fat diets and by 173 
leptin, and decreasing under caloric restriction [20]. Other possible regulators (hormones, 174 
nutrients) remain to be identified, as we have only explored the role of thyroid hormones. D1 175 
and D2 may have distinct functions in WAT, regulating lipogenesis and lipolysis or the 176 
expression of genes and providing the T3 required for specific functions, including the 177 
conversion of WAT into BAT under specific conditions, which would increase energy 178 
expenditure. Each enzyme may have specific functions.  179 
Conclusions 180 
D1 and D2 activities and mRNAs are present in rat WAT. Thyroidal status regulates D1 181 
and D2 mRNA in vivo, both increasing in hypothyroid rats. No changes are found in 182 
deiodinase activities, except for the D2 inhibition by T4+T3.  183 
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Legends to Figures  194 
 195 
Figure 1. Ct values for 18S rRNA, D1 and D2 mRNAs from epididymal rat WAT (panel 196 
A). Relative expression of D1 (panel B) and D2 mRNAs (panel C) versus liver D1 and BAT 197 
D2 mRNAs, respectively. Panels D to G show D1 and D2 mRNAs and activities in WAT 198 
from control (C), thyroidectomized (Tx) and T4+T3 treated thyroidectomized rats. Values 199 
are means ± SEM. * P<0.05 vs C, # P<0.05 vs Tx. (n=4-5/ group). 200 
  201 
Figure 2. T4 and T3 concentrations in plasma, liver and epididymal WAT from control 202 
(C), thyroidectomized (Tx) and T4+T3 treated thyroidectomized rats. Values are means ± 203 
SEM. *P<0.05 vs C, #P<0.05 vs Tx. (n=4-5 /group) 204 
 205 
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